4

OWNERSHIP DOCUMENT

Company: Hepion Pharmaceuticals, Inc.
Filed: February 18, 2021
Period of Report: February 18, 2021
Accession Number: 0001104659-21-025196

View Document ↗ View on SEC.gov ↗